Page 62 - Molecular features of low-grade developmental brain tumours
P. 62
Case Sub- location of Size tumour
(#) Diagnosis Age Gender Mutation group* tumour (mm) re- epilepsy
growth
3
60
CHAPTER 3
Table 1. Summary of clinicopathological features of patients with SEGA and control tissue.
S1a S2a,b
S3a,b
S4a S5a,b
S6a,b S7a,b
S8a,b
S9a,b S10a,b
S11a
S12a S13a,b
S14a,b
S15a
S16a
S17a S18a,b
S19a,b
S20a S21a,b
S22a
SEGA SEGA
SEGA SEGA SEGA SEGA SEGA
SEGA
SEGA SEGA
SEGA
SEGA SEGA
SEGA
SEGA SEGA
SEGA SEGA
SEGA
SEGA SEGA
SEGA
43 Female 7 Male
TSC2 TSC1
NMI TSC1 TSC2 TSC1 TSC2
TSC2
TSC2 TSC2
TSC2
TSC2 TSC2
TSC2
TSC1 TSC2
TSC1 TSC2
NMI
TSC2 TSC1
TSC1
SEGA2b ventricle 19 SEGA1 thirdventricle 7
no yes no yes
36 47 11 16 5
10
8 4
28
32 6
26
53 23
13 13
8
17 13
9
Female Male Female Male Female
Male
Male Male
Female
Male Male
Female
Female
Female
Male Male
Male
Male Female
Male
SEGA2a SEGA2b SEGA1 SEGA1 SEGA1
SEGA1
SEGA1 SEGA1
SEGA2a
SEGA2b SEGA2a
SEGA2a
SEGA2a SEGA2a
SEGA1 SEGA2b
SEGA2b
SEGA2a SEGA2a
SEGA2b
ventricle ventricle ventricle ventricle thirdventricle
ventricle
ventricle ventricle
foramen monro
thirdventricle ventricle
ventricle
foramen monro
ventricle
ventricle
caudate nucleus
caudate nucleus
ventricle ventricle
caudate nucleus
u.k. no u.k. no u.k. no 28 no 66 no
60 no
31 no 18 no
12 no
21 no u.k. yes
14 no
u.k. no
u.k. no
u.k. no 20 no
30 no
40 no 40 no
30 no
yes no no no yes
yes
yes yes
yes
yes u.k.
u.k.
u.k. yes
u.k. yes
yes
no yes
yes
